If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 41 Article
  • 1 Chapter
  • 1 Meeting Abstract
  • 1 Comment/Letter to the editor

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Dorlo, T. P. C., Janssen, J., Niewerth, D., Wilhelm, A. J., Zwaan, C. M., Beijnen, J. H., Attarbaschi, A., Baruchel, A., Fagioli, F., Klingebiel, T., de Moerloose, B., Palumbo, G., von Stackelberg, A., Kaspers, G. J. L. & Huitema, A. D. R., 2019, In : Clinical Pharmacokinetics.

Research output: Contribution to journalArticleAcademicpeer-review

An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia

Kaspers, G. J. L., Niewerth, D., Wilhelm, B. A. J., Scholte-van Houtem, P., Lopez-Yurda, M., Berkhof, J., Cloos, J., de Haas, V., Mathôt, R. A., Attarbaschi, A., Baruchel, A., de Bont, E. S., Fagioli, F., Rössig, C., Klingebiel, T., De Moerloose, B., Nelken, B., Palumbo, G., Reinhardt, D., Rohrlich, P. S. & 3 othersSimon, P., von Stackelberg, A. & Zwaan, C. M., 1 May 2018, In : British Journal of Haematology. 181, 4, p. 523-527 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling

Boons, C. C. L. M., Chahbouni, A., Schimmel, A. M., Wilhelm, A. J., den Hartog, Y. M., Janssen, J. J. W. M., Hendrikse, N. H., Hugtenburg, J. G. & Swart, E. L., 1 Oct 2017, In : Journal of Pharmacy and Pharmacology. 69, 10, p. 1265-1274 10 p.

Research output: Contribution to journalArticleAcademicpeer-review